Dr Reddy's Laboratories is recalling over 8,000 bottles of a generic medication used to prevent rejection of a transplanted organ from the US market due to a packaging error. The Hyderabad-based drug major is recalling 8,280 bottles of Tacrolimus capsules from the US market for ‘presence of foreign tablets/capsules’ in the affected lot. One 0.5 mg Tacrolimus capsule was found in a bottle of 1 mg Tacrolimus capsules. The affected lot was produced at Dr Reddy's Bachupally-based plant near Hyderabad.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
